Sample Collection: Clinical Trials

564 trials of Sample Collection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

227 active not recruiting, 202 recruiting, 60 not yet recruiting, 32 completed. 286 Phase 2, 155 Phase 1, 91 Phase 3, 30 Not applicable, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2286Active not recruiting 136, Recruiting 101, Not yet recruiting 33, Suspended 9, Completed 4, Terminated 2, Withdrawn 1
Phase 1155Recruiting 63, Active not recruiting 58, Not yet recruiting 20, Suspended 9, Terminated 2, Withdrawn 2, Completed 1
Phase 391Active not recruiting 41, Recruiting 36, Not yet recruiting 7, Suspended 4, Completed 2, Terminated 1
Not applicable30Recruiting 14, Not yet recruiting 6, Active not recruiting 5, Completed 4, Suspended 1
Phase 43Not yet recruiting 2, Unknown 1
Early Phase 12Active not recruiting 1, Recruiting 1

Follow Sample Collection: new trials by email Literature Review of Sample Collection trials Research Report on Sample Collection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial
Biospecimen Collection, Cisplatin, Computed Tomography - Resectable Intrahepatic Cholangiocarcinoma
Phase 2Not yet recruitingNorthwestern University442027-12-102026-06-10
Asciminib-Based Induction Therapy for the Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Asciminib, Biospecimen Collection, Blinatumomab - B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Phase 1Not yet recruitingCity of Hope Medical Center212027-10-132026-11-03
Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Biospecimen Collection, Computed Tomography, Futibatinib - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8
Phase 1Not yet recruitingNorthwestern University182027-09-092026-10-20
STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection
Biospecimen Collection, FDG-Positron Emission Tomography and Computed Tomography Scan, Ga-68 PET/CT Scan - Thyroid Gland Medullary Carcinoma
Not applicableNot yet recruitingJonsson Comprehensive Cancer Center1002027-09-022026-10-19
Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase 2Not yet recruitingCity of Hope Medical Center442027-08-042026-09-10
Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma
Biospecimen Collection, Bone Marrow Biopsy, Carboplatin - Recurrent Burkitt Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements
Phase 2 / Phase 3RecruitingNational Cancer Institute (NCI)2712027-07-272026-11-17
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 1RecruitingNational Cancer Institute (NCI)152027-07-052026-11-05
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
Biospecimen Collection, Diagnostic Imaging Testing, Echocardiography Test - Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)312027-06-012026-10-22
Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
Balstilimab, Biopsy Procedure, Biospecimen Collection - Colorectal Adenocarcinoma, Stage II Colorectal Cancer AJCC v8
Phase 2RecruitingNational Cancer Institute (NCI)202027-05-252026-09-29
Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
Biospecimen Collection, Bone Marrow Biopsy, Carfilzomib - Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Phase 2RecruitingNational Cancer Institute (NCI)802027-05-222026-11-04
Study to Test Shorter Duration Chemoradiation Therapy Versus Standard Duration Chemoradiation Therapy for Cervical Cancer
Biospecimen Collection, Brachytherapy, Cisplatin - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma
Phase 3Not yet recruitingNRG Oncology5502027-05-192026-11-10
Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial
Balstilimab, Biospecimen Collection, Botensilimab - Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8
Phase 2RecruitingNational Cancer Institute (NCI)162027-05-172026-10-21
Lenalidomide and Cosibelimab for the Treatment of Relapsed/Refractory Mycosis Fungoides or Sézary Syndrome
Biospecimen Collection, Computed Tomography, Cosibelimab - Recurrent Mycosis Fungoides, Recurrent Sezary Syndrome
Phase 1Not yet recruitingCity of Hope Medical Center142027-05-162026-11-09
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Biospecimen Collection, Chest Radiography, Computed Tomography - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8
Phase 2RecruitingChildren's Oncology Group512027-05-152026-09-24
A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat
Archive Sample Retrieval, Biospecimen Collection, pH Low Insertion Peptide-exatecan Conjugate CBX-12 - Recurrent Childhood Ewing Sarcoma, Recurrent Childhood Malignant Solid Neoplasm
Phase 1 / Phase 2Not yet recruitingChildren's Oncology Group792027-05-072026-09-22
CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 1Not yet recruitingCity of Hope Medical Center362027-05-062026-09-25
Enfortumab Vedotin for the Treatment of Unresectable or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Cancer, or NUT Carcinoma
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Differentiated Thyroid Gland Carcinoma, Metastatic NUT Carcinoma
Phase 2Not yet recruitingNorthwestern University562027-05-052026-10-07
A Vaccine (Nous-209) for the Reduction of Colorectal Lesion Size in Patients With Lynch Syndrome
Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, Biopsy Procedure, Biospecimen Collection - Colorectal Carcinoma, EPCAM Lynch Syndrome
Phase 2Not yet recruitingNational Cancer Institute (NCI)552027-04-272026-11-17
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration - Plasma Cell Leukemia
Phase 2RecruitingNational Cancer Institute (NCI)742027-04-202026-11-18
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 1RecruitingCity of Hope Medical Center162027-04-172026-11-13

Showing 20 of 564. Sign in to see all of them.

Conditions studied

Neoplasm Metastasis (37)  ·  Leukemia, Myeloid, Acute (36)  ·  Lung Neoplasms (28)  ·  Colorectal Neoplasms (26)  ·  Prostatic Neoplasms (24)  ·  Multiple Myeloma (22)  ·  Pancreatic Neoplasms (21)  ·  Breast Neoplasms (20)  ·  Carcinoma, Non-Small-Cell Lung (19)  ·  Lymphoma (19)  ·  Urinary Bladder Neoplasms (18)  ·  Melanoma (17)  ·  Burkitt Lymphoma (16)  ·  Ovarian Neoplasms (15)  ·  Carcinoma, Renal Cell (14)

Sponsors

National Cancer Institute (NCI) (368)  ·  Children's Oncology Group (29)  ·  City of Hope Medical Center (15)  ·  NRG Oncology (13)  ·  Mayo Clinic (12)  ·  Ohio State University Comprehensive Cancer Center (8)  ·  The Wellcome Sanger Institute (8)  ·  University of Washington (6)  ·  ECOG-ACRIN Cancer Research Group (5)  ·  Fred Hutchinson Cancer Center (5)  ·  Jonsson Comprehensive Cancer Center (5)  ·  Northwestern University (5)  ·  University of Michigan Rogel Cancer Center (4)  ·  Columbia University (3)  ·  GlaxoSmithKline (3)

Countries

United States (496)  ·  Canada (87)  ·  Puerto Rico (69)  ·  Australia (24)  ·  United Kingdom (14)  ·  Guam (8)  ·  New Zealand (8)  ·  Belgium (7)  ·  Israel (6)  ·  South Korea (6)  ·  France (5)  ·  South Africa (5)  ·  China (4)  ·  Hong Kong (3)  ·  Italy (3)

Top investigators

A P Chen (7)  ·  Andrea B Apolo (4)  ·  Joyce F Liu (4)  ·  Vikrant V Sahasrabuddhe (4)  ·  Anwaar Saeed (3)  ·  Funda Meric-Bernstam (3)  ·  Haider S Mahdi (3)  ·  Isabel Spriet, PharmD, PhD (3)  ·  Liza C Villaruz (3)  ·  Patricia M LoRusso (3)  ·  Rosa Nadal Rios, MD, PhD (3)  ·  Timothy A Yap (3)  ·  Alain C Mita (2)  ·  Alan L Ho (2)

Results publications

PMID 41671463, PMID 35622074, PMID 37505794, PMID 35031545, PMID 37185961, PMID 40966692, PMID 41911908, PMID 42335416, PMID 23810467, PMID 24929484, PMID 25218906, PMID 25500329, PMID 26247043, PMID 26586415, PMID 27811504, PMID 28223062, PMID 28284873, PMID 29211618, PMID 29223478, PMID 29590047, PMID 29593104, PMID 29784747, PMID 30332335, PMID 30501481, PMID 30581114, PMID 31151904, PMID 31227334, PMID 31401903, PMID 31413177, PMID 31449468, PMID 31945114, PMID 31969335, PMID 32066871, PMID 32463741, PMID 32589970, PMID 32597469, PMID 32853585, PMID 32915679, PMID 32920242, PMID 33020646, PMID 33048619, PMID 33067126, PMID 33152282, PMID 33199817, PMID 33362722, PMID 33394722, PMID 33395032, PMID 33415588, PMID 33591402, PMID 33604999

NIH funding

U10CA180820 (58), U10CA180821 (37), U10CA180868 (36), U10CA180888 (35), U10CA180886 (32), UM1CA186689 (32), UM1CA186709 (26), UM1CA186691 (17), UM1CA186712 (17), UM1CA186717 (17), P30CA033572 (15), UM1CA186644 (15), UM1CA186688 (15), UM1CA186690 (15), P30CA060553 (13)